{"id":5066,"date":"2026-01-12T08:27:45","date_gmt":"2026-01-12T08:27:45","guid":{"rendered":"https:\/\/cognitionconferences.com\/virology\/?post_type=speaker&#038;p=5066"},"modified":"2026-01-12T09:43:17","modified_gmt":"2026-01-12T09:43:17","slug":"maria-gabriella-dona","status":"publish","type":"speaker","link":"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/","title":{"rendered":"Maria Gabriella Dona"},"content":{"rendered":"<p><strong><span style=\"font-size: 10.5pt; font-family: 'Arial',sans-serif; color: #333333;\">Abstract<\/span><\/strong><b><span style=\"font-size: 10.5pt; font-family: 'Arial',sans-serif; color: #333333;\"><br \/>\n<\/span><\/b><span style=\"font-size: 10.5pt; font-family: 'Arial',sans-serif; color: #333333;\"><br \/>\nMore than 200 Human Papillomaviruses (HPV) have been officially established. Around 30 HPVs are mucosotropic and are distinguished in high-risk and low-risk genotypes according to their carcinogenic potential. HPV6 and 11 are not classifiable as to their carcinogenicity to humans, and are responsible for more than 90% of the ano-genital warts. For 12 HPVs (e.g., HPV16 and 18), there is instead sufficient evidence of their carcinogenicity in humans. They are the aetiological agents of cervical, vulvar, vaginal, penile, anal, as well as head and neck squamous cell carcinomas (SCC). HPV contribution to these neoplasias ranges between 25% and virtually 100% of cases according to the type of cancer. Up to 98% of anal SCCs (ASCC) diagnosed in men living with HIV are etiologically related to HPV. This virus also has a role in the development of oropharyngeal SCC (OPSCC). The proportion of OPSCCs attributable to HPV has been estimated to be 45% in Europe, but significant geographical differences exist. The substantial rise in ASCC and OPSCC incidence observed in recent years has fostered the interest on the burden of anal and oral HPV infection. The epidemiology of these infections will be outlined, along with an overview of the neoplastic lesions caused at the level of the anal canal and head and neck region. Finally, data on the time trend of ano-genital wart diagnoses will be provided, in light of the availability of the prophylactic vaccination for the prevention of HPV6 and 11 infections.<\/span><\/p>\n","protected":false},"featured_media":5074,"template":"","meta":{"_acf_changed":false},"schedule":[],"speaker-category":[],"class_list":["post-5066","speaker","type-speaker","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Maria Gabriella Dona - Cognition Conferences<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Maria Gabriella Dona - Cognition Conferences\" \/>\n<meta property=\"og:description\" content=\"Abstract More than 200 Human Papillomaviruses (HPV) have been officially established. Around 30 HPVs are mucosotropic and are distinguished in high-risk and low-risk genotypes according to their carcinogenic potential. HPV6 and 11 are not classifiable as to their carcinogenicity to humans, and are responsible for more than 90% of the ano-genital warts. For 12 HPVs [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/\" \/>\n<meta property=\"og:site_name\" content=\"Cognition Conferences\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-12T09:43:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cognitionconferences.com\/virology\/wp-content\/uploads\/2026\/01\/Picture-Jacson-Ferreira.pdf-2-724x1024.png\" \/>\n\t<meta property=\"og:image:width\" content=\"724\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/\",\"url\":\"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/\",\"name\":\"Maria Gabriella Dona - Cognition Conferences\",\"isPartOf\":{\"@id\":\"https:\/\/cognitionconferences.com\/virology\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cognitionconferences.com\/virology\/wp-content\/uploads\/2026\/01\/Picture-Jacson-Ferreira.pdf-2.png\",\"datePublished\":\"2026-01-12T08:27:45+00:00\",\"dateModified\":\"2026-01-12T09:43:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/#primaryimage\",\"url\":\"https:\/\/cognitionconferences.com\/virology\/wp-content\/uploads\/2026\/01\/Picture-Jacson-Ferreira.pdf-2.png\",\"contentUrl\":\"https:\/\/cognitionconferences.com\/virology\/wp-content\/uploads\/2026\/01\/Picture-Jacson-Ferreira.pdf-2.png\",\"width\":1414,\"height\":2000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cognitionconferences.com\/virology\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Maria Gabriella Dona\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cognitionconferences.com\/virology\/#website\",\"url\":\"https:\/\/cognitionconferences.com\/virology\/\",\"name\":\"Cognition Conferences\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cognitionconferences.com\/virology\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Maria Gabriella Dona - Cognition Conferences","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/","og_locale":"en_US","og_type":"article","og_title":"Maria Gabriella Dona - Cognition Conferences","og_description":"Abstract More than 200 Human Papillomaviruses (HPV) have been officially established. Around 30 HPVs are mucosotropic and are distinguished in high-risk and low-risk genotypes according to their carcinogenic potential. HPV6 and 11 are not classifiable as to their carcinogenicity to humans, and are responsible for more than 90% of the ano-genital warts. For 12 HPVs [&hellip;]","og_url":"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/","og_site_name":"Cognition Conferences","article_modified_time":"2026-01-12T09:43:17+00:00","og_image":[{"width":724,"height":1024,"url":"https:\/\/cognitionconferences.com\/virology\/wp-content\/uploads\/2026\/01\/Picture-Jacson-Ferreira.pdf-2-724x1024.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/","url":"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/","name":"Maria Gabriella Dona - Cognition Conferences","isPartOf":{"@id":"https:\/\/cognitionconferences.com\/virology\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/#primaryimage"},"image":{"@id":"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/#primaryimage"},"thumbnailUrl":"https:\/\/cognitionconferences.com\/virology\/wp-content\/uploads\/2026\/01\/Picture-Jacson-Ferreira.pdf-2.png","datePublished":"2026-01-12T08:27:45+00:00","dateModified":"2026-01-12T09:43:17+00:00","breadcrumb":{"@id":"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/#primaryimage","url":"https:\/\/cognitionconferences.com\/virology\/wp-content\/uploads\/2026\/01\/Picture-Jacson-Ferreira.pdf-2.png","contentUrl":"https:\/\/cognitionconferences.com\/virology\/wp-content\/uploads\/2026\/01\/Picture-Jacson-Ferreira.pdf-2.png","width":1414,"height":2000},{"@type":"BreadcrumbList","@id":"https:\/\/cognitionconferences.com\/virology\/speaker\/maria-gabriella-dona\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cognitionconferences.com\/virology\/"},{"@type":"ListItem","position":2,"name":"Maria Gabriella Dona"}]},{"@type":"WebSite","@id":"https:\/\/cognitionconferences.com\/virology\/#website","url":"https:\/\/cognitionconferences.com\/virology\/","name":"Cognition Conferences","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cognitionconferences.com\/virology\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/cognitionconferences.com\/virology\/wp-json\/wp\/v2\/speaker\/5066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cognitionconferences.com\/virology\/wp-json\/wp\/v2\/speaker"}],"about":[{"href":"https:\/\/cognitionconferences.com\/virology\/wp-json\/wp\/v2\/types\/speaker"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cognitionconferences.com\/virology\/wp-json\/wp\/v2\/media\/5074"}],"wp:attachment":[{"href":"https:\/\/cognitionconferences.com\/virology\/wp-json\/wp\/v2\/media?parent=5066"}],"wp:term":[{"taxonomy":"schedule","embeddable":true,"href":"https:\/\/cognitionconferences.com\/virology\/wp-json\/wp\/v2\/schedule?post=5066"},{"taxonomy":"speaker-category","embeddable":true,"href":"https:\/\/cognitionconferences.com\/virology\/wp-json\/wp\/v2\/speaker-category?post=5066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}